ser performance evaluation of 4 blood glucose monitoring systems based on ISO 15197:2013 / EN ISO 15197:2015
- Conditions
- E14Unspecified diabetes mellitus
- Registration Number
- DRKS00028602
- Lead Sponsor
- Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 112
Signed informed consent form
- Subjects are legally competent and capable to understand character, meaning and consequences of the study.
- Pregnancy or lactation period if venous samples are needed
- Severe acute disease that compromises the subject’s capability to participate in the study (at the study physician’s discretion)
- Severe chronic disease with potential risk during the test procedures (at the study physician’s discretion)
- Medical relevant anemia
- Suspected lack of compliance
- Dependence on investigator or sponsor
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.